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A glycoconjugate of Haemophilus 
influenzae Type b capsular 
polysaccharide with tetanus 
toxoid protein: hydrodynamic 
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carbohydrate
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Pierre Duvivier5, Karel Conrath5 & Stephen E. Harding1
Three important physical properties which may affect the performance of glycoconjugate vaccines 
against serious disease are molar mass (molecular weight), heterogeneity (polydispersity), and 
conformational flexibility in solution. The dilute solution behaviour of native and activated capsular 
polyribosylribitol (PRP) polysaccharides extracted from Haemophilus influenzae type b (Hib), and 
the corresponding glycoconjugate made by conjugating this with the tetanus toxoid (TT) protein 
have been characterized and compared using a combination of sedimentation equilibrium and 
sedimentation velocity in the analytical ultracentrifuge with viscometry. The weight average molar 
mass of the activated material was considerably reduced (Mw ~ 0.24 × 106 g.mol−1) compared to the 
native (Mw ~ 1.2 × 106 g.mol−1). Conjugation with the TT protein yielded large polydisperse structures 
(of Mw ~ 7.4 × 106 g.mol−1), but which retained the high degree of flexibility of the native and activated 
polysaccharide, with frictional ratio, intrinsic viscosity, sedimentation conformation zoning behaviour 
and persistence length all commensurate with highly flexible coil behaviour and unlike the previously 
characterised tetanus toxoid protein (slightly extended and hydrodynamically compact structure 
with an aspect ratio of ~3). This non-protein like behaviour clearly indicates that it is the carbohydrate 
component which mainly influences the physical behaviour of the glycoconjugate in solution.
Haemophilus influenzae is a small non-motile Gram negative bacterium1,2 present in the nasopharynx of approx-
imately 75 % of healthy children and adults and is regarded as normal flora3. A minority (~3–7%) of healthy 
individuals intermittently harbour the carbohydrate encapsulated H. influenzae strains (types a, b, c, d, e, and f ) 
in the upper respiratory tract4. It was mistakenly thought to be the cause of influenza disease: as a consequence it 
was named accordingly5,6. However the considered opinion now is that H. influenzae is most likely to have been 
an important secondary invader to the influenza virus in the 1890 pandemic and many subsequent influenza 
epidemics. Nonetheless it is still considered responsible for a wide range of clinical diseases such as meningitis 
and pneumonia3,7.
Invasive diseases caused by H. influenzae seem to occur in humans only and are primarily due to type b 
Haemophilus influenzae or “Hib” (> 95% of cases) where it remains a major cause of acute bacterial meningitis. 
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Until the availability of the Hib vaccine, the type b H. influenzae was the main cause of meningitis in children 
between 6 months and 5 years old, although older children, adolescents and adults can also be infected8.
Since 1931 it has been known that some strains of Haemophilus influenzae possess a polysaccharide cap-
sule and that there are 6 capsular serotypes (a–f )9. In 1953, Zamenhof and co-workers10 postulated that the 
type-specific substance of Haemophilus influenzae type b, was composed of polyribose-ribitol chains with (3→ 5) 
phosphate diester linkages between the ribose moieties. Further work11–14 established the double ribose unit as 
β -D-Ribf-/β -D-Ribf. Anderson and colleagues15 and Schneerson and coworkers16 have also reported equimolar 
ratios of phosphorus and ribose. Thus, the polyribosyl ribitol phosphate (PRP) capsule of Hib is a linear copol-
ymer composed of repeated units of→ 3)-β-D-Ribf-(1→ 1)-D-ribitol-(5-OPO3→ [(C10H19O12P)n] with a defined 
molecular size2,17. The size of the polysaccharide used for conjugation should be defined and controlled.
Unlike other bacteria (e.g Streptococcus pneumoniae and Neisseria meningitidis) the type b polysaccharide 
capsule of H. influenzae is attractive as a vaccine antigen since invasive disease is almost exclusively restricted to 
only one serotype, which in turn has rendered its capsular polysaccharide a prime candidate for vaccine studies. 
The first generation of Hib vaccine was based on the purified type b capsular polysaccharide and its ribose-ribitol 
phosphate repeating units2,18–20. Conjugation of the polysaccharide with a suitable protein to stimulate a stronger 
and longer lasting T-cell based immunity21 has been the target of research. Connaught Laboratories (now Sanofi 
Pasteur) produced the first licensed Hib conjugate vaccine in 1987 after the pioneering work by Schneerson and 
co-workers22, through random conjugation of PRP to diphtheria toxoid. Following on the heels of this vaccine 
three other vaccines from the biopharmaceutical companies, namely Wyeth (now Pfizer), Sanofi-Pasteur and 
Merck, all differing in their carrier protein and method of conjugation, received approval from the Food and Drug 
Administration (FDA)2. Recently approved glycoconjugate vaccines include a Hib-Tetanus toxoid (TT) conju-
gate Hiberix® and a novel Hib-MenCY-TT (MenHibrix®) by GSK Vaccines. MenHibrix® vaccine administered in 
accordance to the current Hib vaccine schedule (USA) would have the potential to induce protective antibodies 
against Hib and meningococcal-CY disease in children23.
Important to their function as a vaccine is the structure and stability of the polysaccharide and conjugates 
thereof. Molecular weight (molar mass) and molar mass distribution have been documented as being the most 
important physical parameters affecting the immunogenicity of capsular polysaccharides24,25. While many other 
aspects of polysaccharide characterisation have been relatively thoroughly explored26–28, the physical charac-
terisation of capsular polysaccharides (molecular size and mass distribution and conformational flexibility) has 
been less extensively pursued. Such physical studies for capsular polysaccharides have been generally limited to 
low pressure chromatographic analyses calibrated with “standards” and more recently to high performance size 
exclusion chromatography (SEC) coupled to on-line refractive index detector (RI), multi-angle light scattering 
(MALS). In this study we used the analytical ultracentrifuge due to its larger dynamic range (molar masses from 
103 to > 108 g.mol−1), particularly appropriate for large glycoconjugates, many of which are beyond the exclusion 
limit of SEC-MALS29. This study is designed principally to characterise the purified native and activated capsular 
polyribosylribitol polysaccharides (PRP) from Haemophilus influenzae type b (referred to as PRP native and 
PRP-ADH respectively) as well as the final PRP- TT conjugate (with a polysaccharide: protein ratio of ca. 0.4) 
and to establish whether it is the protein component or carbohydrate component which principally influences the 
physical or hydrodynamic properties in solution This study has also been designed to demonstrate the usefulness 
of analytical ultracentrifuge based procedures – all not requiring a separation column or matrix - in the charac-
terisation of large glycoconjugate vaccines.
Results
Sedimentation velocity in the analytical ultracentrifuge was first applied as the primary method for assessing the 
size heterogeneity. Bimodal plots of apparent sedimentation coefficient distributions g*(s) versus s were seen in 
the case of both native Hib polysaccharide (Fig. 1a) and the ADH activated Hib (Fig. 1b) whereas a unimodal 
profile for the much larger conjugate structure was observed (Fig. 1c). This does not mean that the conjugate was 
monodisperse as the broadness of the peak is commensurate with a broad distribution of sizes of a (quasi-) con-
tinuous type arising from polydispersity of the carbohydrate chains. Under these conditions Hib polysaccharides 
and conjugate have apparent weight average sedimentation coefficients ranging from 5.9S to 30S as reported in 
Table 1. All three showed classical dependencies of s20,w on c, (decrease of s20,w with increase of c) indicative of 
non-ideality and the absence of significant reversible associative effects (Fig. 2).
Molar mass values estimated from sedimentation equilibrium using the SEDFIT-MSTAR and MFIT algo-
rithms for weight-average molar mass and z-average molar mass, respectively are shown in Table 1 with an 
example of a determination for the PRP-TT conjugate in Fig. 3. The weight average molar mass values for the gly-
coconjugate obtained using the matrix-free technique of sedimentation in the analytical ultracentrifuge29 appear 
to be commensurate with a recent study by Lockyer and coworkers30 using size exclusion chromatography (SEC) 
coupled to multi-angle light scattering, but without the problem of large molar mass species (> 2 × 106) eluting 
in the void volume of the SEC.
The sedimentation coefficient distribution – which itself gives a good measure of sample heterogeneity - for 
Hib PRP-TT conjugate was then transformed into a corresponding distribution of molar mass using the Extended 
Fujita Approach of Harding et al.31 (Fig. 4).
The transformation is as follows:
.=f M / g s( ) (ds dM) ( ) (1)
with
κ=M s( / ) (2)s
b1/
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and
κ= . . −ds dM b s/ (3)s
b b b1/ ( 1)/
b is a conformation parameter that has already been estimated for a number of polysaccharides32 and κ s can be 
found from equation (3) provided that at least one value of M (e.g. Mw from sedimentation equilibrium) is known 
for one value of s (e.g. the weight average s value). The distributions so obtained for two plausible values of b are 
shown in Fig. 4. The broad distribution is completely different for the sharp monomer-dimer distribution we 
observed earlier for TT by itself 33.
For macromolecules of known molar mass the intrinsic viscosity [η ] can provide an important measure of the 
conformational flexibility (especially when used in conjunction with the sedimentation coefficient, so20,w, and the 
Figure 1. Sedimentation coefficient distributions, g*(s) vs s profiles, at different concentrations for (a) Hib PRP-
native capsular polysaccharide (b) Hib PRP-ADG (c) Hib PRP-TT conjugate. The apparent sharpening of the 
peaks as the concentration increases is due to “hypersharpening” through the combined effects of polydispersity 
and non-ideality: the faster moving species in a distribution are slowed down by having to sediment through a 
solution of the slower ones. These effects diminish as the concentration is reduced.
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concentration dependence coefficient ks). Three different and complementary extrapolation methods values to 
zero concentration (to eliminate complications through non-ideality effects) were used for all 3 samples – all gave 
good agreement and are shown in Table 1.
Sample so20,w (S) ks mL.g−1 10−3 × Mwa g.mol−1 10−3 × Mzb g.mol−1 [η]c mL.g−1 [η]d mL.g−1 [η]e mL.g−1 ks/[η] f/fo
PRP-native 5.9 ± 0.2 400 ± 40 1200 ± 50 1250 ± 60 447 ± 14 445 ± 8 445 ± 6 0.9 ± 1 9.8
PRP-ADH 6.0 ± 0.2 260 ± 40 240 ± 10 325 ± 20 275 ± 4 273 ± 3 275 ± 3 0.9 ± 2 3.3
PRP-TT 30.0 ± 0.5 190 ± 10 7300 ± 420 7700 ± 390 225 ± 2 224 ± 6 224 ± 4 0.9 ± 1 6.4
TTf monomer 7.6 ± 0.1 150 ± 5 5.7 ± 0.1 5.7 ± 0.1 1.3
TTf dimer 11.6 ± 0.2 270 ± 15
Table 1.  Hydrodynamic properties for Hib PRP-native, Hib PRP-ADH and Hib PRP-TT derivatives. 
In phosphate-chloride buffer (pH = 6.8, I = 0.10). aSedimentation equilibrium SEDFIT-MSTAR analysis. 
bSedimentation equilibrium MFIT analysis. cHuggins extrapolation procedure. dKraemer extrapolation 
procedure. eSolomon-Ciuta procedure. ffrom ref. 33.
Figure 2. Concentration dependence (reciprocal) sedimentation coefficient plot for Hib PRP-native, Hib 
PRP-ADH and Hib PRP-TT, to remove the effects on non-ideality. Sedimentation coefficients measured in 
the phosphate chloride buffer (pH = 6.8, I = 0.10) had been normalized to standard conditions (the viscosity 
and density of water at a temperature of 20.0 °C).
Figure 3. SEDFIT-MSTAR output for analysis of Hib PRP-TT conjugate at a loading concentration of 
0.3 mg.mL−1 to find the (apparent) weight average molar mass Mw,app over the whole distribution. (a) The 
operational point average molar mass M*(r) plotted as a function of radial position from the centre of rotation r. 
Mw,app, the (apparent) weight average molar mass for the whole distribution being measured = M* extrapolated 
to the radial position at the cell base. Retrieved Mw,app from this extrapolation = (7.3 ± 0.4) × 106 g.mol−1. (b) 
Plot of the “point” or “local” apparent average molar mass Mw,app(r) at radial positions r, as a function of local 
concentration c(r) in the ultracentrifuge cell. The “hinge point” corresponds to the radial position where the 
c(r) = the initial loading concentration. At this hinge point Mw,app(r) = (7.3 ± 0.5) × 106 g.mol−1. Although not as 
precise a way of estimating Mw,app from the sedimentation equilibrium records it does provide an internal check 
for consistency.
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Discussion
The hydrodynamic data collectively enable us to establish what is the conformational flexibility of the Hib glyco-
conjugate and to establish whether it is either the protein component or the carbohydrate component which is 
more strongly influencing the hydrodynamic properties. There are four approaches, one using the sedimentation 
data alone, the others using various combinations.
Conformational analysis: translational frictional ratio. The translational frictional ratio, f/fo is a 
parameter which depends on conformation and molecular expansion through hydration effects34. It can be meas-
ured experimentally from the sedimentation coefficient and molar mass:
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where NA is Avogadro’s number. f is the friction coefficient of the molecule and fo the corresponding value for a 
spherical particle of the same mass and (anhydrous) volume31. Departures from f/fo = 1 are due to either asymme-
try (for example the modest asymmetries seen in the tetanus toxoid protein – Table 1 and ref. 33) or an increase 
in volume due to swelling through particle solvation effects – the high values in Table 1 could be due to either (or 
both) and without other information it is impossible to distinguish between the two. Combination with viscosity 
data and how viscosity and the sedimentation coefficient change with molar mas, however, help us to be more 
specific.
Conformational analysis: the Wales-van Holde ratio. The Wales-van Holde ratio35, R = ks/[η] - where 
ks is the concentration dependence of the sedimentation coefficient or “Gralen” coefficient - is perhaps the sim-
plest indicator of a macromolecules conformational flexibility in solution. The limits are ~1.6 for a compact 
sphere or a non-draining random coil, and ~0.1 for a stiff rod36. From Table 1 it seems that the values for the 
polysaccharide and glycoconjugate are identical (R ~ 0.9) and consistent with a flexible coil structure.
Conformational analysis: Estimation of the Persistence Length Lp. For a more quantitative esti-
mate of chain flexibility we can use the persistence length Lp, which has theoretical limits of 0 for a random coil 
and ∞ for a stiff rod. Practically the limits are ∼ 1–2 nm for a random coil (such as the polysaccharide pullulan) 
and ∼ 200–300 nm for a very stiff rod shaped macromolecule (such as xanthan or schizophyllan)29. Several meth-
ods are available for the estimation of Lp using either intrinsic viscosity37–39 or sedimentation coefficient40 meas-
urements. For example the Bohdanecky-Bushin relation
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where φ is the Flory-Fox coefficient (2.86 × 1023 mol−1) and A0 and B0 are tabulated coefficients, and the 
Yamakawa–Fujii equation40
Figure 4. Molar mass distribution f(M) profile from sedimentation velocity for Hib PRP-TT conjugate. 
Obtained by transforming the sedimentation coefficient distribution of Fig. 1c by the Extended Fujita method, 
using the weight average sedimentation coefficient with the weight average Mw,app (from Fig. 3) molar mass and 
two different plausible values of the conformation parameter b. The broad distribution is completely different 
for the sharp monomer-dimer distribution we observed earlier for TT by itself 33.
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Yamakawa and Fujii39 showed that A2 can be considered as –ln(d/2Lp) and A3 = 0.1382 if the Lp is much higher 
than the chain diameter, d. Difficulties arise if the mass per unit length is not known, although both relations have 
recently been built into an algorithm Multi-HYDFIT40 which estimates the best estimates or best range of values 
of Lp and ML based on minimization of a target function Δ. An estimate for the chain diameter d is also required 
but extensive simulations have shown that the results returned for Lp are relatively insensitive to the value chosen 
for d which was fixed at an average of ∼ 0.8 nm41,42. ML and Lp were treated as variables and the minimum value 
of the target function Δ was estimated on a 2D contour plot for each sample (see Fig. 5) and the values esti-
mated given in Table 2. All the values are consistent with flexible random coil structures with persistence lengths 
between 4.5 and 7 nm.
Sedimentation Conformation Zoning. This high flexibility is confirmed by “Sedimentation 
Conformation Zoning”, introduced by Pavlov et al.43,44. This involves plotting ksML versus [s]/ML, onto a zonal 
Figure 5. Plot of mass per unit length ML versus persistence length Lp evaluation using the multi-HYDFIT 
procedure of Ortega and Garcia de la Torre41. (a) the Hib PRP-native polysaccharide. The plot yields 
Lp ∼ 7.0 × 10−7 (cm) and ML ∼ 3.8 × 109 (g.mol−1.cm−1) at the minimum target (error) function (indicated by 
the white cross). (b) Hib PRP-ADH, Lp ∼ 7.0 × 10−7 (cm) and ML ∼ 6.0 × 109 (g. mol−1. cm−1); (c) Hib PRP-TT 
Lp ∼ 4.5 × 10−7 (cm) and ML ∼ 10.7 × 109 (g. mol−1. cm−1).
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template established from macromolecules of known conformation type. ks is the Gralen coefficient, ML the mass 
per unit length and the “intrinsic” sedimentation coefficient [s] is given by:
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with η 20,w and ρ 20,w the viscosity and density of water at 20.0 °C, and v the partial specific volume. Figure 6 – con-
firms that both the native and activated polysaccharides, and the glycoconjugate are all highly flexible structures 
(falling just within the Zone D area – randomly coiled structures), and not too different with capsular polysaccha-
rides from Streptococcus pneumoniae45 (Zone C – semi-flexible). The tetanus toxoid protein by itself - slightly 
extended and hydrodynamically compact34 – is by contrast a “Zone E” particle.
All four conformation approaches (frictional ratio, Wales-van Holde ratio, persistence length and con-
formation zoning) show that conjugation with the tetanus protein yielded large polydisperse structures of 
(Mw ~ 7.3 × 106 g/mol), but which retained the high flexibility of the native and activated polysaccharide, similar 
to what we found earlier for capsular polysaccharides from Streptococcus pneumoniae45 – and very different for 
the previously characterised tetanus toxoid protein34, as summarized in Table 1. These findings supplement other 
biophysical studies on other glycoconjugate vaccines. The high flexibility arising from carbohydrate chains is 
consistent for example with the 1H-NMR relaxation studies of Berti and coworkers46 on Hib conjugated to the 
non-toxic mutant of diphtheria toxin CRM197: this work also provided evidence of reduced hydration of the 
protein as a result of the conjugation. Using circular dichroism and fluorescence spectroscopy and 1H-NMR, the 
protein component of Hib and MenC glycoconjugate vaccines was nonetheless found to be important for pH and 
thermal stability47,48. In more recent work Pecetta49 and coworkers have provided evidence based on differential 
scanning calorimetry and circular dichroism of conjugation causing some structural changes of the CRM197 
protein.
Concluding Remarks. The flexible chain-like hydrodynamic properties of the PRP-TT glycoconjugates are 
commensurate with those of a polysaccharide rather than a protein. Tetanus toxoid protein is known to be a 
globular protein of aspect ratio ~3:1 with a tendancy to form small amounts of dimer (~14%)34. Intrinsic vis-
cosities of the protein are small and typical of globular proteins and very different from the Hib polysaccharide 
and glycoconjugate. This clearly indicates that it is the carbohydrate component which most strongly influences 
the physical behaviour of these substances in solution. This study has also shown the usefulness of the analytical 
ultracentrifuge as a matrix free method for ‘quality control’ assessment of the heterogeneity and conformational 
flexibility of the Hib vaccine preparations.
Sample 10−7 × ML (g.mol−1.cm−1) 107 × Lp (cm)
PRP-native 380 ± 50 7.0 ± 1.0
PRP-ADH 600 ± 50 7.0 ± 1.2
PRP-TT 1070 ± 50 4.5 ± 0.3
Table 2.  Values for the mass per unit length ML and the persistence length Lp from global hydrodynamic 
analysis for PRP-native, PRP-ADH and PRP-TT.
Figure 6. Conformation Zoning plot, Hib PRP-native, PRP-ADH and PRP-TT conjugate (with spacer) all 
have very flexible structures in the “Zone D” region close to Zone C Zone A: Rigid rod with no flexibility; 
Zone B: Rigid rod with some flexibility; Zone C: Semi-flexible coil; Zone D: Random coil; Zone E: Globular 
or heavily branched structures. See ref. 56.
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Methods
Sample preparation. The bulk Hib manufacturing process consists of the following steps: after initial solid 
preculture steps, the bacteria are incubated in shake flasks. Once the appropriate cell density is reached, the 
inoculum is transferred to a fermentor for further amplification. The virulent strain of Hib is grown in a medium 
supplemented with hematin and nicotinamide adenine dinucleotide (NAD). During the growth phase, the pH is 
regulated with concentrated NaOH solution and the dissolved oxygen is regulated by the stirring speed and air 
flow rate. At the onset of the drift phase (7–8 hours after inoculation), the pH and dissolved oxygen regulations are 
switched off and the parameters are left to drift. The fermentation is terminated 10 hours after the inoculation. The 
broth containing the polyribosyl (PRP) polysaccharide of interest is inactivated by heat and centrifuged to remove 
cell debris. Purification is assured by Hib precipitation with Cetavlon in the presence of Celite. The complex PRP-
CTAB is an insoluble complex retained on the Celite. The PRP polysaccharide is detached from the Cetavlon by 
using a high salt concentration (0.5 M NaCl). The product is ultrafiltered to eliminate residual nucleic acids, then 
precipitated with ethanol, dried and kept at − 20 °C until conjugation. The residuals (DNA (< 0.2%), proteins 
(< 0.1%), LPS(< 0.03%)) were very low in the final bulk of polysaccharide and met all the required specifications 
of the pharmacopeia (WHO/EMEA).
Hib PRP-polysaccharide activation (using adipic acid dihydrazide as linker) prior to its conjugation was using 
the cyanogen bromide method50–52. By-products were removed by further ultrafiltration (30 kDa cut-off). The 
conjugation process did not involve oxidization of PRP with periodic acid: the PRP is directly activated. After 
activation (6 minutes), the ADH is added to form a covalent polysaccharide-ADH product which is then able to 
be conjugated with the –COOH groups of the tetanus toxoid (TT) protein by using carbodimide conjugation. 
The conjugation between the activated (PRP-ADH) and the TT protein was performed using EDC (1-ethyl-3-
(3-dimethylaminopropyl)-carbodimide hydrochloride)53,54. The Hib PRPTT conjugate was then purified on a 
Sephacryl S500HR column using 0.2 M NaCl as the elution solution. The conjugate was then sterile filtered before 
a final ultrafiltration step, which led to the product meeting the required specifications of the pharmacopeia, with 
< 15% of unconjugated polysaccharide and < 5% unconjugated protein. All samples were dissolved in phosphate 
buffered saline pH ~6.8, I = 0.1 M55, at 20.0 °C and mixed by magnetic stirring at room temperature for 24 hours. 
All solutions were then diluted to the appropriate (total macromolecular) concentrations required.
Sedimentation velocity in the analytical ultracentrifuge. A general description of the ultracentrifu-
gal methods and how they can be used for glycoconjugate and polysaccharide characterisation is given in two 
recent references29,56. Specifically for this study sedimentation velocity experiments were performed using a 
Beckman (Palo Alto, CA, USA) Optima XL-I analytical ultracentrifuge equipped with Rayleigh interference 
optics and an automatic on-line data capture system. Conventional 12 mm double-sector epoxy cells with sap-
phire windows were loaded with 400 μL of different (total macromolecular) concentrations (0.1–2.0 mg mL−1) of 
each sample and a matching amount of the corresponding reference buffer (phosphate buffered saline) in appro-
priate channels. Samples were run at a rotor speed of 45000 rpm (~150,000 g) at a temperature of 20.0 °C. 
Concentration profiles and the movement of the sedimenting boundary in the analytical ultracentrifuge cell were 
recorded using the Rayleigh interference optical system and converted to concentration (in units of fringe dis-
placement relative to the meniscus, j) versus radial position, r26. Data was analysed using the least squares bound-
ary ls-g*(s) model incorporated into the SEDFIT analytical algorithm of Dam & Schuck57. SEDFIT generates an 
apparent distribution of sedimentation coefficients in the form of g*(s) versus s, where s is the sedimentation 
coefficient (in Svedberg units S = 10−13 sec). The * indicates the profiles are not corrected for diffusion broadening 
(likely to be small for slow-diffusing polysaccharides and glycoconjugates). This data analysis was followed by the 
correction to standard solvent conditions - namely the density and viscosity of water at 20.0 °C - to yield s20,W 
using the algorithm SEDNTERP58, which also incorporates the partial specific volume (v) of the samples 
v ~ 0.63 mL.g−1. To account for hydrodynamic non-ideality (co-exclusion and backflow effects), the apparent sed-
imentation coefficients (s20,w) were calculated at a series of different cell loading concentration and extrapolated 
to infinite dilution using the Gralén relation59:
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where ks is the Gralén or concentration dependence coefficient.
Sedimentation equilibrium in the analytical ultracentrifuge. Sedimentation equilibrium experi-
ments were also performed using the Beckman (Palo Alto, CA, USA) Optima XL-I analytical ultracentrifuge 
again using the Rayleigh interference optics and an automatic on-line data capture system to record equilibrium 
concentration distribution profiles. The modified long (20 mm) optical path length double-sector titanium cells 
with sapphire windows were selected and loaded with 0.070 mL of solution (dialysed at room temperature against 
the phosphate buffered saline for 48 hours) and a matching amount of reference buffer dialysate in the appropriate 
channels. Samples were centrifuged at rotor speeds selected to give a sufficient fringe increment from meniscus 
to base60 i.e. 4000 rpm (~1200 g), 9000 rpm (~5900 g) and 2000 rpm (~300 g) for PRP native, PRP-ADH and the 
PRP-TT solution, respectively, at a temperature of 20.0 °C. Scans were taken every one hour and equilibrium was 
reached after approximately 48–72 hours. Optical records (Rayleigh interference profiles) of the relative concen-
tration distribution of the solute at equilibrium were analysed to give the weight (mass) average apparent molar 
mass Mw,app using the SEDFIT-MSTAR algorithm61. This uses the M* function of Creeth and Harding62, together 
with the hinge point method (evaluation of the point or weight average molar mass at the radial position in the 
distribution where the local (total macromolecule) concentration c(r) = the initial loading concentration, c61). 
The use of long path length cells meant that low loading concentrations could be used to give a sufficient signal 
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(~0.3 mg.mL−1). At such low concentrations, non-ideality effects (which tend to lead to underestimates of the 
molar mass) may be relatively small and we make the approximation that the apparent weight average molar mass 
Mw,app is equal to the true weight average molar mass Mw60. We also estimate the apparent z-average molar mass 
Mz,app using the MFIT algorithm of Ang and Rowe63.
Viscometry. Dynamic viscosity measurements for Hib native, Hib-ADH and Hib-TT, were carried out using 
the automated micro-viscometer Anton Parr AMVn (Anton Parr, Graz, Austria) at a concentration series (total 
macromolecular concentration) from 0.1–2.0 mg mL−1 based on the rolling ball viscosity method in which the 
apparatus measures the time of a (silanized) steel ball needed to roll in a 1.6 mm diameter silanized glass capil-
lary containing the sample. The experiment was performed at different reclining angles of 70° n = 4 times), 60° 
(n = 4 times) and 50° (n = 6 times) under precise temperature control (20.00 ± 0.01 °C). Huggins64 and Kraemer65 
extrapolations forms (see, also ref. 38) were performed to obtain the intrinsic viscosity (Equations 9, 10). Intrinsic 
viscosities were also estimated using the Solomon – Ciutâ relation (Equation 11)66.
η η η= + K c[ ](1 [ ] ) (9)red H
η
η η= −
ln
c
K c[ ](1 [ ] ) (10)
rel
K
η
η η
=
− − ln
c
[ ]
[2( 1) 2 ( )]
(11)
rel rel
1/2
where c is the concentration, K H  and K K are the Huggins and Kraemer coefficients, repectively.
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